Drug-eluting stents for acute myocardial infarction

Bibliography

• Rosamond W, Flegal K, Friday G, et al. Heart disease and stroke statistics 2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2007;115:69-171
   PubMed Web of Science ®Google Scholar
• Keely EC, Boura JA, Griness CL. Primary angioplasty versus intravenous trombolytic therapy for acute myocardial infarction. A quantitative review of 23 randomized trials. Lancet 2003;361:13-20
   PubMed Web of Science ®Google Scholar
• Nordmann AJ, Bucher H, Hengstler, et al. Primary stenting versus primary balloon angioplasty for treating acute myocardial infarction. Cochrane Database Syst Rev 2005;2:CD005313
   Google Scholar
• Zhu MM, Feit A, Chadow H, et al. Primary stent implantation compared with primary balloon angioplasty for acute myocardial infarction: a meta-analysis of randomized clinical trials. Am J Cardiol 2001;88:297-301
   PubMedGoogle Scholar
• Suryapranata H, De Luca G, van't Hof AW, et al. Is routine stenting for acute myocardial infarction superior to balloon angioplasty? A randomized comparison in a large cohort of unselected patients. Heart 2005;91:641-5
   PubMed Web of Science ®Google Scholar
• Stone GW, Grines CL, Cox DA, et al. Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. N Engl J Med 2002;346:957-66
   PubMed Web of Science ®Google Scholar
• Maillard L, Hamon M, Khalife K, et al. Comparison of systematic stenting and conventional balloon angioplasty during primary percutaneous transluminal coronary angioplasty for acute myocardial infarction. STENTIM-2 Investigators. J Am Coll Cardiol 2000;35:1729-36
   PubMed Web of Science ®Google Scholar
• Morice MC, Serruys PW, Sousa JE, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002;346:1773-80
   PubMed Web of Science ®Google Scholar
• Stone GW, Ellis SG, Cox DA, et al. A polymer-based, paclitaxel- eluting stent in patients with coronary artery disease. N Engl J Med 2004;350:221-31
   PubMed Web of Science ®Google Scholar
• Patel TN, Bavry AA, Kumbhani DJ, Ellis SG. A meta-analysis of randomized trials of rescue percutaneous coronary intervention after failed fibrinolysis. Am J Cardiol 2006;97(12):1685-90
   PubMedGoogle Scholar
• Collet JP, Montalescot G, Le May M, et al. Percutaneous coronary intervention after fibrinolysis: a multiple meta-analyses approach according to the type of strategy. J Am Coll Cardiol 2006;48(7):1326-3
   PubMed Web of Science ®Google Scholar
• Wijeysundera HC, Vijayaraghavan R, Nallamothu BK, et al. Rescue angioplasty or repeat fibrinolysis after failed fibrinolytic therapy for ST-segment myocardial infarction: a meta-analysis of randomized trials. J Am Coll Cardiol 2007;49(4):422-30
   PubMedGoogle Scholar
• Sutton AG, Campbell PG, Graham R, et al. A randomized trial of rescue angioplasty versus a conservative approach for failed fibrinolysis in ST-segment elevation myocardial infarction: the Middlesbrough Early Revascularization to Limit INfarction (MERLIN) trial. J Am Coll Cardiol 2004;44(2):287-96
   PubMed Web of Science ®Google Scholar
• Kunadian B, Vijayalakshmi K, Dunning J, et al. Towards an understanding of the role of rescue angioplasty for failed fibrinolysis: comparison of the MERLIN, RESCUE and REACT trials. J Invasive Cardiol 2007;19(9):359-68
   PubMedGoogle Scholar
• Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994;343(8893):311-22
   PubMed Web of Science ®Google Scholar
• Eagle KA, Goodman SG, Avezum A, et al. Practice variation and missed opportunities for reperfusion in ST-segment-elevation myocardial infarction: findings from the Global Registry of Acute Coronary Events (GRACE). Lancet 2002;359(9304):373-7
   PubMed Web of Science ®Google Scholar
• Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 2003;361(9351):13-20
   PubMed Web of Science ®Google Scholar
• The GUSTO Angiographic Investigators. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. N Engl J Med 1993;329(22):1615-22
   PubMed Web of Science ®Google Scholar
• Herrmann HC. Triple therapy for acute myocardial infarction: combining fibrinolysis, platelet IIb/IIIa inhibition, and percutaneous coronary intervention. Am J Cardiol 2000;85(8A):10-16
   Google Scholar
• Grines CL, Browne KR, Marco J, et al. A comparison of primary angioplastywith thrombolytic therapy for acute myocardial infarction. N Engl J Med 1993;328:673-9
   PubMed Web of Science ®Google Scholar
• Stone GW, Grines CL, Browne KF, et al. Predictors of in-hospital and 6 month outcome after acute myocardial infarction in the reperfusion era: the Primary Angioplasty in Myocardial Infarction (PAMI) trial. J Am Coll Cardiol 1995;25:370-7
   PubMedGoogle Scholar
• Zijlstra F, DeBoer MJ, Hoorntje JCA, et al. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med 1993;328:680-4
   PubMed Web of Science ®Google Scholar
• Gibbons RJ, Holmes DR, Reeder GS, et al. Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. N Engl J Med 1993;328:685-91
   PubMed Web of Science ®Google Scholar
• Michels KB, Yusuf S. Does PTCA in acute myocardial infarction affect mortality and reinfarction rates? A quantitative (meta-analysis) of the randomized clinical trials. Circulation 1995;91:476-85
   PubMed Web of Science ®Google Scholar
• Stone GW, Grines CL, Browne KF, et al. Implications of recurrent ischemia after reperfusion therapy in acute myocardial infarction: a comparison of thrombolytic therapy and primary coronary angioplasty. J Am Coll Cardiol 1995;26:66-72
   PubMed Web of Science ®Google Scholar
• O'Neill WW, Brodie BR, Ivanhoe R, et al. Primary coronary angioplasty for acute myocardial infarction (the Primary Angioplasty Registry). Am J Cardiol 1994;73:627-34
   PubMed Web of Science ®Google Scholar
• Stone GW, Rutherford BD, McConahay DR, et al. Direct coronary angioplasty in acute myocardial infarction: outcome in patients with single vessel disease. J Am Coll Cardiol 1990;15:534-43
   PubMedGoogle Scholar
• Rothbaum DA, Linnemeier TJ, Landin RJ, et al. Emergency percutaneous transluminal coronary angioplasty in acute myocardial infarction: a 3-year experience. J Am Coll Cardiol 1987;10:264-72
   PubMed Web of Science ®Google Scholar
• O'Keefe JH, Bailey WL, Rutherford BD, et al. Primary angioplasty for acute myocardial infarction in 1000 consecutive patients. Am J Cardiol 1993;72:107-15
   Google Scholar
• Miller PF, Brodie BR, Weintraub RA, et al. Emergency coronary angioplasty for acute myocardial infarction. Arch Intern Med 1987;147:1565-70
   PubMedGoogle Scholar
• Grines CL, Marsalese DL, Brodie B, et al. Safety and cost-effectiveness of early discharge after primary angioplasty in low risk patients with acute myocardial infarction. PAMI-II Investigators. Primary angioplasty in myocardial infarction. J Am Coll Cardiol 1998;31(5):967-72
   PubMed Web of Science ®Google Scholar
• Stone GW, Marsalese D, Brodie BR, et al. A prospective, randomized evaluation of prophylactic intraaortic balloon counterpulsation in high risk patients with acute myocardial infarction treated with primary angioplasty. J Am Coll Cardiol 1997;29:1459-67
   PubMedGoogle Scholar
• Ishihara M, Sato H, Tateishi H, et al. Intraaortic balloon pumping as the post angioplasty strategy in acute myocardial infarction. Am Heart J 1991;122:385-9
   PubMedGoogle Scholar
• Ohman EM, Califf RM, George BS, et al. and the Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group. The use of intraaortic balloon counterpulsation as an adjunct to reperfusion therapy in acute myocardial infarction. Am Heart J 1991;191:895-901
   Google Scholar
• Ohman EM, George BS, White CJ, et al. for the Randomized IABP Study Group. Use of aortic counterpulsation to improve sustained coronary artery patency during acute myocardial infarction: results of a randomized trial. Circulation 1994;90:792-9
   PubMedGoogle Scholar
• Ohman EM, Califf RM, Topol EJ, et al. Consequences of reocclusion after successful reperfusion therapy in acute myocardial infarction. Circulation 1990;82:781-91
   PubMed Web of Science ®Google Scholar
• Brodie BR, Grines CL, Ivanhoe R, et al. Six-month clinical and angiographic follow-up after direct angioplasty for acute myocardial infarction. Circulation 1994;25:156-62
   Google Scholar
• Al Suwaidi J, Holmes DR Jr, Salam AM, et al. Impact of coronary artery stents on mortality and nonfatal myocardial infarction: metaanalysis of randomized trials comparing a strategy of routine stenting with that of balloon angioplasty. Am Heart J 2004;147:815-22
   PubMed Web of Science ®Google Scholar
• Mehta RH, Harjai KJ, Cox DA, et al. Comparison of coronary stenting versus conventional balloon angioplasty on five-year mortality in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention. Am J Cardiol 2005;96:901-6
   PubMedGoogle Scholar
• Stone GW, Brodie BR, Griffin JJ, et al. Clinical and angiographic follow-Up after primary stenting in acute myocardial infarction: the Primary Angioplasty in Myocardial Infarction (PAMI) stent pilot trial. Circulation 1999;99(12):1548-54
   PubMed Web of Science ®Google Scholar
• Stenestrand U, Lindback J, Wallentin L, et al. Long-term outcome of primary percutaneous coronary intervention vs prehospital and in-hospital thrombolysis for patients with ST-elevation myocardial infarction. JAMA 2006;296:1749-56
   PubMed Web of Science ®Google Scholar
• Newell MC, Henry CR, Sigakis CJ, et al. Comparison of safety and efficacy of sirolimus-eluting stents versus bare metal stents in patients with ST-segment elevation myocardial infarction. Am J Cardiol 2006;97:1299-302
   PubMedGoogle Scholar
• Weber F, Schneider H, Schwarz C, et al. Sirolimus-eluting stents for percutaneous coronary intervention in acute myocardial infarction Lesson from a case-controlled comparison of bare metal versus drug-eluting stents in thrombusladen lesions. Z Kardiol 2004;93:938-43
   PubMedGoogle Scholar
• Lemos PA, Saia F, Hofma SH, et al. Short and long term clinical benefit of sirolimus-eluting stents compared to conventional bare stents for patients with acute myocardial infarction. J Am Coll Cardiol 2004;43:704-8
   PubMed Web of Science ®Google Scholar
• Cheneau E, Rha SW, Kuchulakanti PK, et al. Impact of sirolimus-eluting stents on outcomes of patients treated for acute myocardial infarction by primary angioplasty. Catheter Cardiovasc Interv 2005;65:469-72
   PubMedGoogle Scholar
• Schömig A, Ndrepepa G, Mehilli J, et al. A randomized trial of coronary stenting versus balloon angioplasty as a rescue intervention after failed thrombolysis in patients with acute myocardial infarction. J Am Coll Cardiol 2004;44(10):2073-9
   PubMed Web of Science ®Google Scholar
• Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003;349:1315-23
   PubMed Web of Science ®Google Scholar
• Morice MC, Serruys PW, Sousa JE, et al. Randomized study with the sirolimus-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo native coronary artery lesions. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002;346:1773-80
   PubMed Web of Science ®Google Scholar
• Van de Werf F. Drug-eluting stents in acute myocardial infarction. N Engl J Med 2006;355:1169-70
   PubMedGoogle Scholar
• Kupferwasser LI, Amorn AM, Kapoor N, et al. Comparison of drug-eluting stents with bare metal stents in unselected patients with acute myocardial infarction. Catheter Cardiovasc Interv 2007;70(1):1-8
   PubMedGoogle Scholar
• Zhang F, Ge J, Qian J, et al. Sirolimus-eluting stents in real-world patients with ST-segment elevation acute myocardial infarction. Int Heart J 2007;48(3):303-11
   PubMedGoogle Scholar
• Daemen J, Tanimoto S, García-García HM, et al. Comparison of three-year clinical outcome of sirolimus- and paclitaxel-eluting stents versus bare metal stents in patients with ST-segment elevation myocardial infarction (from the RESEARCH and T-SEARCH Registries). Am J Cardiol 2007;99(8):1027-32
   PubMed Web of Science ®Google Scholar
• Kukreja N, Onuma Y, Garcia H, et al. Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction Circulation: Cardiovasc Interv 2008;1:103-10
   Google Scholar
• Mauri L, Silbaugh TS, Garg P, et al. Drug-eluting or bare-metal stents for acute myocardial infarction. N Engl J Med 2008;359(13):1330-42
   PubMedGoogle Scholar
• Kastrati A, Dibra A, Spaulding C, et al. A. Meta-analysis of randomized trials on drug-eluting stents vs. bare-metal stents in patients with acute myocardial infarction. Eur Heart J 2007;28(22):2706-13
   PubMed Web of Science ®Google Scholar
• Pittl U, Kaiser C, Brunner-La Rocca HP, et al. Safety and efficacy of drug eluting stents versus bare metal stents in primary angioplasty of patients with acute ST-elevation myocardial infarction – a prospective randomized study [abstract]. Eur Heart J 2006;27:650-650
   Google Scholar
• Helsinki Area Acute Myocardial Infarction Treatment Re-Evaluation-Should the Patients Get a Drug-Eluting or Normal Stent (HAAMU-STENT) trial. Available from: wwwcardiosourcecom/pops/trialSumasp?trialID=1492 (5 March 2007)
   Google Scholar
• Laarman GJ, Suttorp MJ, Dirksen MT, et al. Paclitaxel-eluting versus uncoated stents in primary percutaneous coronary intervention. N Engl J Med 2006;55:1105-13
   Google Scholar
• Di Lorenzo E, Varricchio A, Lanzillo T, et al. Paclitaxel and sirolimus stent implantation in patients with acute myocardial infarction [abstract]. Circulation 2005;112:U538-U538
   Google Scholar
• A prospective randomized controlled trial to evaluate the efficacy of drug-eluting stents versus bare-metal stents for the treatment of acute myocardial infarction (MISSION trial). Availlable from: wwwcardiosourcecom/clinicaltrials/browseAcronymasp?alpha=M (5 March 2007)
   Google Scholar
• Spaulding C, Henry P, Teiger E, et al. for the TYPHOON Investigators. Sirolimus-eluting versus uncoated stents in acute myocardial infarction. N Engl J Med 2006;55:1093-104
   Google Scholar
• Valgimigli M, Percoco G, Malagutti P, et al. Tirofiban and sirolimus-eluting stent vs abciximab and bare-metal stent for acute myocardial infarction: a randomized trial. JAMA 2005;293:2109-17
   PubMed Web of Science ®Google Scholar
• Menichelli M, Parma A, Pucci E, et al. Randomized trial of sirolimus-eluting stent versus bare-metal stent in acute myocardial infarction (SESAMI). J Am Coll Cardiol 2007;49:1924-30
   PubMed Web of Science ®Google Scholar
• Hannan LE, Racz M, Walford G. Drug-eluting versus bare-metal stents in the treatment of patients with ST-Segment Elevation Myocardial Infarction. J Am Coll Cardiol Intv 2008;1:129-35
   Google Scholar
• Valgimigli M, Campo G, Percoco G, et al. Comparison of angioplasty with infusion of tirofiban or abciximab and with implantation of sirolimus-eluting or uncoated stents for acute myocardial infarction: the MULTISTRATEGY randomized trial. JAMA 2008;299(15):1788-99
   PubMed Web of Science ®Google Scholar
• HORIZONS-AMI trial 1-year data was presented at 2008 TCT Meeting. Available from: http://www.theheart.org/article/print.do?primaryKey=911985
   Google Scholar
• Lagerqvist B, James SK, Stenestrand U, et al. SCAAR Study Group Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med 2007;356(10):1009-19
   PubMed Web of Science ®Google Scholar
• Moreno R, Spaulding C, Laarman GJ, et al. Effectiveness and safety of paclitaxel-eluting stents in patients with ST-segment elevation acute myocardial infarction. Euro Interv 2007;3:386-91
   Google Scholar
• Niitsu Y, Jakubowski JA, Sugidachi A, Asai F. Pharmacology of CS-747 (prasugrel, LY640315), a novel, potent antiplatelet agent with in vivo P2Y12 receptor antagonist activity. Semin Thromb Hemost 2005;31:184-94
   PubMed Web of Science ®Google Scholar
• Brandt JT, Payne CD, Wiviott SD, et al. A comparison of prasugrel and clopidogrel loading doses on platelet function: magnitude of platelet inhibition is related to active metabolite formation. Am Heart J 2007;153:66.e9-66.e16
   PubMed Web of Science ®Google Scholar
• Jernberg T, Payne CD, Winters KJ, et al. Prasugrel achieves greater inhibition of platelet aggregation and a lower rate of non-responders compared with clopidogrel in aspirin-treated patients with stable coronary artery disease. Eur Heart J 2006;27:1166-73
   PubMed Web of Science ®Google Scholar
• Wallentin L, Varenhorst C, James S, et al. Prasugrel achieves greater and faster P2Y12 receptor-mediated platelet inhibition than clopidogrel due to more efficient generation of its active metabolite in aspirin-treated patients with coronary artery disease. Eur Heart J 2008;29(1):21-30
   PubMed Web of Science ®Google Scholar
• Wiviott SD, Trenk D, Frelinger AL, et al. Prasugrel compared with high loading- and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: the Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation-Thrombolysis in Myocardial Infarction 44 trial. Circulation 2007;116(25):2923-32
   PubMed Web of Science ®Google Scholar
• Wiviott SD, Antman EM, Winters KJ, et al. Randomized comparison of prasugrel (CS-747, LY640315), a novel thienopyridine P2Y12 antagonist, with clopidogrel in percutaneous coronary intervention: results of the Joint Utilization of Medications to Block Platelets Optimally (JUMBO)-TIMI 26 trial. Circulation 2005;111:3366-73
   PubMed Web of Science ®Google Scholar
• Wiviott SD, Braunwald E, McCabe CH, et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2007;357(20):2001-15
   PubMed Web of Science ®Google Scholar
• Assali AR, Moustapha A, Sdringola S, et al. Acute coronary syndrome may occur with in-stent restenosis and is associated with adverse outcomes (the PRESTO trial). Am J Cardiol 2006;98(6):729-33
   PubMedGoogle Scholar
• Eisenstein EL, Anstrom KJ, Kong DF, et al. Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA 2007;297(2):159-68
   PubMed Web of Science ®Google Scholar
• Fox KA, Mehta SR, Peters R, et al. Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial. Circulation 2004;110:1202-8
   PubMed Web of Science ®Google Scholar